{"id":"W2070812863","doi":"10.1016/j.jval.2013.08.448","title":"Potential Long-Term Cost Savings Due to Significant Clinical Benefit of Obinutuzumab (Ga101) in Combination with Chlorambucil in Previously Untreated Chronic Lymphocytic Leukemia","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Obinutuzumab; Chlorambucil; Medicine; Chronic lymphocytic leukemia; Bendamustine; Population; Ofatumumab; Rituximab; Internal medicine; Leukemia; Oncology; Chemotherapy; Lymphoma; Environmental health; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006113091,0.0003769432,0.0005575473,0.000305614,0.0001997179,0.0008224166,0.0004093071,0.0005546826,0.003188387],"category_scores_gemma":[0.001635635,0.0001238537,0.0008088856,0.000386944,0.0002958358,0.000491672,0.0004132176,0.0009122742,0.0002717227],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001397829,"about_ca_system_score_gemma":0.0008781956,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001802433,"about_ca_topic_score_gemma":0.003404286,"domain_scores_codex":[0.9995796,0.0002213172,0.00002025811,0.00002388348,0.00005467567,0.0001002264],"domain_scores_gemma":[0.9994547,0.0002311988,0.0001065289,0.00001987415,0.00003094716,0.0001567166],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.2102282,0.003653464,0.04783975,0.0008613163,0.002156726,0.004103839,0.0001701016,0.02292001,0.04408023,0.003820718,0.005729672,0.654436],"study_design_scores_gemma":[0.03979944,0.1657062,0.596816,0.001381888,0.01289474,0.01649036,0.001446903,0.04869555,0.047203,0.0106895,0.05858341,0.0002930403],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9710402,0.01848082,0.0007533142,0.003223302,0.0001587318,0.00007630683,0.000329002,0.00003968253,0.005898613],"genre_scores_gemma":[0.9976793,0.001364799,0.0002448676,0.0001521027,0.00006334084,0.000014237,0.0001105663,0.000004246021,0.0003664131],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003188387,"threshold_uncertainty_score":0.01066625,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0337281984678595,"score_gpt":0.329314392531407,"score_spread":0.2955861940635475,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}